GRGTX | VIVAX | GRGTX / VIVAX | |
Total Expense Ratio | 0.75 | 0.17 | 441% |
Annual Report Gross Expense Ratio | 0.95 | 0.17 | 559% |
Fund Existence | 18 years | 33 years | - |
Gain YTD | 2.850 | 2.237 | 127% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 397M | 189B | 0% |
Annual Yield % from dividends | 1.50 | 2.16 | 69% |
Returns for 1 year | 3.09 | 6.74 | 46% |
Returns for 3 years | 24.38 | 32.22 | 76% |
Returns for 5 years | 44.01 | 70.82 | 62% |
Returns for 10 years | 62.13 | 102.09 | 61% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CZOVX | 26.64 | 0.01 | +0.04% |
Zacks All-Cap Core Institutional | |||
HDVFX | 14.04 | N/A | N/A |
Hartford International Equity F | |||
MYIIX | 8.97 | -0.01 | -0.11% |
NYLI WMC International Research Eq Cl I | |||
SVACX | 6.06 | -0.01 | -0.16% |
Federated Hermes Strategic Value Div C | |||
KTCSX | 41.77 | -0.09 | -0.22% |
DWS Science and Technology S |